These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26836192)

  • 21. Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.
    Tetzloff KA; Graff-Radford J; Martin PR; Tosakulwong N; Machulda MM; Duffy JR; Clark HM; Senjem ML; Schwarz CG; Spychalla AJ; Drubach DA; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    J Alzheimers Dis; 2018; 62(4):1713-1724. PubMed ID: 29614676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR, (18)F-FDG, and (18)F-AV45 PET correlate with AD PSEN1 original phenotype.
    Saint-Aubert L; Payoux P; Hannequin D; Barbeau EJ; Campion D; Delisle MB; Tafani M; Viallard G; Péran P; Puel M; Chollet F; Demonet JF; Pariente J
    Alzheimer Dis Assoc Disord; 2013; 27(1):91-4. PubMed ID: 22517194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease.
    Iaccarino L; Tammewar G; Ayakta N; Baker SL; Bejanin A; Boxer AL; Gorno-Tempini ML; Janabi M; Kramer JH; Lazaris A; Lockhart SN; Miller BL; Miller ZA; O'Neil JP; Ossenkoppele R; Rosen HJ; Schonhaut DR; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2018; 17():452-464. PubMed ID: 29159058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer's disease, whereas amyloid deposition does not.
    Sang S; Pan X; Chen Z; Zeng F; Pan S; Liu H; Jin L; Fei G; Wang C; Ren S; Jiao F; Bao W; Zhou W; Guan Y; Zhang Y; Shi H; Wang Y; Yu X; Wang Y; Zhong C
    Alzheimers Res Ther; 2018 Mar; 10(1):26. PubMed ID: 29490669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.
    Ng KP; Pascoal TA; Mathotaarachchi S; Chung CO; Benedet AL; Shin M; Kang MS; Li X; Ba M; Kandiah N; Rosa-Neto P; Gauthier S;
    Neurology; 2017 May; 88(19):1814-1821. PubMed ID: 28404803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probable Novel APP Met671Leu Mutation in a Chinese Han Family with Early-Onset Alzheimer's Disease.
    Ma L; Wang F; Chen S; Wang S; Wang Z; Xia M; Li Y; Ma H; Shang J; Zhang J
    Neuromolecular Med; 2024 Mar; 26(1):6. PubMed ID: 38504005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease.
    Li X; Westman E; Thordardottir S; Ståhlbom AK; Almkvist O; Blennow K; Wahlund LO; Graff C
    J Alzheimers Dis; 2017; 56(1):327-334. PubMed ID: 27911308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.
    Fodero-Tavoletti MT; Okamura N; Furumoto S; Mulligan RS; Connor AR; McLean CA; Cao D; Rigopoulos A; Cartwright GA; O'Keefe G; Gong S; Adlard PA; Barnham KJ; Rowe CC; Masters CL; Kudo Y; Cappai R; Yanai K; Villemagne VL
    Brain; 2011 Apr; 134(Pt 4):1089-100. PubMed ID: 21436112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.
    Mosconi L; Rinne JO; Tsui WH; Berti V; Li Y; Wang H; Murray J; Scheinin N; Någren K; Williams S; Glodzik L; De Santi S; Vallabhajosula S; de Leon MJ
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5949-54. PubMed ID: 20231448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tau positron emission tomography using [
    Kang JM; Lee SY; Seo S; Jeong HJ; Woo SH; Lee H; Lee YB; Yeon BK; Shin DH; Park KH; Kang H; Okamura N; Furumoto S; Yanai K; Villemagne VL; Seong JK; Na DL; Ido T; Cho J; Lee KM; Noh Y
    Neurobiol Aging; 2017 Nov; 59():210-219. PubMed ID: 28890300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suspecting Non-Alzheimer's Pathologies and Mixed Pathologies: A Comparative Study Between Brain Metabolism and Tau Images.
    Malotaux V; Colmant L; Quenon L; Huyghe L; Gérard T; Dricot L; Ivanoiu A; Lhommel R; Hanseeuw B
    J Alzheimers Dis; 2024; 97(1):421-433. PubMed ID: 38108350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.
    Gordon BA; Blazey TM; Su Y; Hari-Raj A; Dincer A; Flores S; Christensen J; McDade E; Wang G; Xiong C; Cairns NJ; Hassenstab J; Marcus DS; Fagan AM; Jack CR; Hornbeck RC; Paumier KL; Ances BM; Berman SB; Brickman AM; Cash DM; Chhatwal JP; Correia S; Förster S; Fox NC; Graff-Radford NR; la Fougère C; Levin J; Masters CL; Rossor MN; Salloway S; Saykin AJ; Schofield PR; Thompson PM; Weiner MM; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
    Lancet Neurol; 2018 Mar; 17(3):241-250. PubMed ID: 29397305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroPET Imaging Assessment of Brain Tau and Amyloid Deposition in 6 × Tg Alzheimer's Disease Model Mice.
    Kang S; Kim J; Lee SY; Okamura N; Chang KA
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease.
    Pardo JV; Lee JT;
    eNeuro; 2018; 5(1):. PubMed ID: 29497704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later.
    Nägga K; Gustavsson AM; Stomrud E; Lindqvist D; van Westen D; Blennow K; Zetterberg H; Melander O; Hansson O
    Neurology; 2018 Jan; 90(1):e73-e81. PubMed ID: 29196581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diverging Relationships among Amyloid, Tau, and Brain Atrophy in Early-Onset and Late-Onset Alzheimer's Disease.
    Na HK; Shin JH; Kim SW; Seo S; Kim WR; Kang JM; Lee SY; Cho J; Byun J; Okamura N; Seong JK; Noh Y
    Yonsei Med J; 2024 Aug; 65(8):434-447. PubMed ID: 39048319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer's Disease with APP Osaka Mutation.
    Shimada H; Minatani S; Takeuchi J; Takeda A; Kawabe J; Wada Y; Mawatari A; Watanabe Y; Shimada H; Higuchi M; Suhara T; Tomiyama T; Itoh Y
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity.
    Huijbers W; Schultz AP; Papp KV; LaPoint MR; Hanseeuw B; Chhatwal JP; Hedden T; Johnson KA; Sperling RA
    J Neurosci; 2019 Jan; 39(3):548-556. PubMed ID: 30482786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional patterns of 18F-florbetaben uptake in presenilin 1 mutation carriers.
    Sala-Llonch R; Falgàs N; Bosch B; Fernández-Villullas G; Balasa M; Antonell A; Perissinotti A; Pavía J; Campos F; Lladó A; Lomeña F; Sánchez-Valle R
    Neurobiol Aging; 2019 Sep; 81():1-8. PubMed ID: 31207465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease.
    Whitwell JL; Graff-Radford J; Tosakulwong N; Weigand SD; Machulda MM; Senjem ML; Spychalla AJ; Vemuri P; Jones DT; Drubach DA; Knopman DS; Boeve BF; Ertekin-Taner N; Petersen RC; Lowe VJ; Jack CR; Josephs KA
    Alzheimers Dement; 2018 Aug; 14(8):1005-1014. PubMed ID: 29605222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.